● Recruiting

Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes

Condition: Primary Biliary Cholangitis · Sponsor: Zydus Therapeutics Inc.

PhasePhase 3

Planned participants386

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Long-Term Study to Evaluate the Safety and Efficacy in Participants with Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes (EPICS-V)

This description comes directly from the study's public registry record.

Talk to the study team

Farheen Shaikh · +1-609-453-4751 · fshaikh@zydustherapeutics.com

Deven Parmar · +1-609-946-9340 · dparmar@zydustherapeutics.com

Always discuss trial participation with your own doctor first.

Locations (3)

Zydus US104	Marietta, Georgia, United States	Recruiting
Zydus US101	Indianapolis, Indiana, United States	Recruiting
Zydus US105	Houston, Texas, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07216235